Both in Pharmaceuticals
Yarrow Bioscience vs Pyxis Oncology
Over the past year YARW returned −32.0% and PYXS returned −48.9%; their daily moves had a correlation of 0.40.
YARW −32.0% PYXS −48.9%Growth of $1, one year, split-adjusted
| Metric | YARW | PYXS |
|---|---|---|
| Price | $18.37 | $1.64 |
| Market cap | $155.0M | $136.8M |
| Today | +2.45% | −2.96% |
| 1 month | −9.5% | −26.8% |
| 6 months | — | −10.4% |
| Year to date | — | +42.6% |
| 1 year | — | −53.9% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 12.4× |
| Net cash | — | $33.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 112.4% |
| Short % of float | 2.0% | 7.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).